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The costs of overweight
The Article by Seamus Kent and colleagues1 presents 
an analysis of the overall inpatient costs in women in 
England aged 50–64 years with different body-mass 
index (BMI) values on admission in 2006 who were 
taking part in the Million Women Study.2 Clearly the 
lowest hospital costs and the lowest rate of hospital 
admission were in women with BMIs between 
20 kg/m² and 22·5 kg/m², which is consistent with the 
WHO analysis that the optimum BMI is about 21 kg/m².3 
The risk of diabetes and other chronic diseases increases 
progressively from a BMI of about 20–21 kg/m² in 
non-smokers. This contrasts with a BMI of 25 kg/m² for 
specifying thresholds on the basis of a clear increase in 
mortality rather than morbidity. What are still needed 
though are detailed analyses of costing attributable 
to increased BMI at all ages and both sexes. Reliable 
extrapolation from these analyses alone would be 
impossible.
Only 18% of the women in this cohort were obese; 
however, after these self-reported weights were 
corrected, the real prevalence of obesity was revealed 
to be 23%, which is consistent with Zaninotto and 
colleagues’analyses.4 With these adjusted figures, the 
optimum BMI range of 20–22·5 kg/m² was the same 
whether using the original or adjusted BMI figures, 
with a progressive increase in admissions not only 
for diabetes and other chronic conditions but also 
for the weight-related musculoskeletal problems 
including arthritis, particularly of the knees. The effect 
of diabetes was underestimated because only the 
presenting diagnosis (usually a general practitioner 
responsibility) was taken into account in the assessment 
of the underlying cause even though cardiovascular 
complications are a common reason for hospital 
admission in people with diabetes, and, during the 
5 years of the study, the number of patients with 
designated diabetes at presentation trebled.
Traditionally doctors have focused on severely 
obese patients, but these new analyses emphasise the 
importance of considering the whole range of excessive 
BMIs. Kent and colleagues’ research shows that of all 
the hospital costs incurred by the overweight patients, 
only 13% could be attributed to their weight condition. 
However, the total additional costs to the UK National 
Health Service (NHS) from having women with a BMI 
of 25–29·9 kg/m² were 30% of the total extra costs from 
all the women with a BMI of 25 kg/m² or more. This cost 
compares similarly with a value of 44·3% in the USA,5 
despite the USA having a higher proportion of obese 
people than England. This difference might be due to a 
greater willingness of surgeons in the fee paying USA 
than in England to operate when overweight women 
have musculoskeletal disorders, including arthritis.
When assessing the real effect of diabetes in England 
for the Chief Scientist’s Foresight analysis of future 
prospects for obesity,6 we found that diabetes proved to 
be the substantial component of costs. Furthermore, the 
costs were best prevented, not simply by undertaking 
an intervention to halve the numbers of obese patients, 
but by measures that dropped the mean BMI of the 
whole adult population. The other intriguing result 
was that for all the emphasis on childhood obesity, it 
will not have a material effect on hospital costs for the 
next 40 years because it takes time for all the major 
complications of being overweight or obese to become 
sufficiently severe to warrant hospital interventions. 
The present analyses also refer only to middle-aged 
women, but women aged 70 years and older account for 
a substantial part of health service costs and the number 
of these women is expected to increase. As such, Kent 
and colleagues’ research represents a low estimate of 
the total costs of increased BMI. Furthermore, these 
analyses do not account for outpatient visits, general 
prescription costs, or primary health-care services; 
obesity accounted for 0·7–2·8% of all health costs when 
assessed 10 years ago.7 If these costs are included, then 
it is no wonder that Simon Stevens (chief executive 
of NHS England) considers obesity to be the biggest 
future threat to the NHS in England.8 Furthermore, 
if we estimate the proportion of the disease burden 
attributable to all the different risk factors, then having 
a BMI of more than 23 (taken as the optimum BMI upper 
limit) is estimated to be only the 11th biggest burden 
on society globally.9 The disease burden of overweight 
or obesity is the 5th biggest concern for policy makers 
in high-income countries and 3rd in the Middle East and 
North Africa.10
Many health economists are now focusing on the 
broad societal costs of being overweight, including 
early retirement, efficiency at work, and prospects of 
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promotion. These societal costs are now estimated to 
account for 60% of the total costs of being overweight 
or obese.11 In 2014, the McKinsey Institute estimated 
the economic burden of being overweight or obese 
at US$2 trillion, matching that of smoking and all 
armed conflict.12 So now really is the time that we start 
implementing coherent prevention policies, even if 
many doctors still underestimate the cost of obesity. 
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